ACR Meeting Abstracts

ACR Meeting Abstracts

  • Meetings
    • ACR Convergence 2024
    • ACR Convergence 2023
    • 2023 ACR/ARP PRSYM
    • ACR Convergence 2022
    • ACR Convergence 2021
    • ACR Convergence 2020
    • 2020 ACR/ARP PRSYM
    • 2019 ACR/ARP Annual Meeting
    • 2018-2009 Meetings
    • Download Abstracts
  • Keyword Index
  • Advanced Search
  • Your Favorites
    • Favorites
    • Login
    • View and print all favorites
    • Clear all your favorites
  • ACR Meetings

Abstract Number: 1531

Characterization of Cytokine/chemokine Profile in Patient-derived M1/ M2 Macrophages to Identify Biomarkers for Genetically-defined Systemic Autoinflammatory Diseases

Farzana Bhuyan1, Adriana Almeida de Jesus2, Kim Johnson3, Jacob Mitchell4, Yan Huang5 and Raphaela Goldbach-Mansky5, 1NIH, bhetesda, MD, 2Translational Autoinflammatory Disease Section (TADS)/NIAID/NIH, Bethesda, 3NIH, NIAID, Bethesda, 4Translational Autoinflammatory Disease Section (TADS)/NIAID/NIH, Bethesda, MD, 5NIH, Bethesda

Meeting: ACR Convergence 2020

Keywords: Autoinflammatory diseases, chemokines, cytokines, innate immunity, macrophages

  • Tweet
  • Click to email a link to a friend (Opens in new window) Email
  • Click to print (Opens in new window) Print
Session Information

Date: Monday, November 9, 2020

Title: Cytokines & Cell Trafficking Poster

Session Type: Poster Session D

Session Time: 9:00AM-11:00AM

Background/Purpose: Genetic mutations in key regulatory molecules of the innate immune system cause autoinflammatory diseases through propagation of hyperinflammatory responses. Monocytes/ macrophages regulate inflammatory processes during infection and homeostasis by secreting a wide range of cytokines and chemokines that control recruitment and migration of immune cells to inflamed tissue, and their biological functions through immune cell differentiation and polarization. We characterized the cytokine/chemokine profile of peripheral blood monocyte-derived M1-, and M2-macrophages (M1-, M2-MDMs) from patients (pts) with genetically defined systemic autoinflammatory diseases (SAIDs) and controls.

Methods: Whole blood from pts enrolled in the IRB approved study (NCT 02974595) with IL-1 mediated  SAIDs NOMID (n=3), DIRA (n=4), Majeed Syndrome (n=1); interferon-mediated diseases CANDLE (n=3) SAVI (n=3); IL-18 mediated diseases NLRC4-MAS (n=2), IL-18PAP-MAS(n=1), Blau syndrome (n=4), NEMO-NDAS (n=3); and healthy controls (HC) (n=6) were assessed. M1-, M2-MDMs) from culture with GM-CSF or M-CSF for 6 days were assessed with and without LPS+ATP stimulation. Human Cytokine Array and ELISA were used for cytokine/chemokine profiling. SAVI monocytes died upon in vitro M1-M2 MDM differentiation. Differentiation into rounded and flat shaped M1-MDMs and elongated or spindle shaped M2-MDMs was 80-90% and 70-80% respectively for all samples.

Results: IL-1β secretion from M1-MDMs was higher in NOMID, DIRA and Majeed syndrome pts upon stimulation with LPS and ATP compared to HC and other SAID pts. In NOMID pts, IL-1b was equally elevated in M1-and M2 MDMs, whereas IL-18 was produced in M1- and M2-MDMs in NLRC4-MAS and in M2-MDMs in IL-18PAP-MAS. TNF and IL-6 were highest in stimulated M1-MDMs in NOD2 and NLRC4 MAS pts. compared to HC (p< 0.05) and in stimulated M2-MDMs in Majeed, CANDLE, NOD2 and NLRC4 pts. Among chemokines, CCL2/MCP-1 which recruit monocyte into inflamed tissues was constitutively expressed in M1/M2-MDMs of CANDLE and NOD2 and M1-MDM of NLRC4-MAS pts. M2-MDMs derived from Majeed and DIRA pts. produced significantly higher levels of CCL5/RANTES and CXCL10/IP-10 (p< 0.05). IP-10 secretion was not seen in CANDLE or NEMO-NDAS. IL-8 and CXCL1, two neutrophil-attracting chemokines were high in most autoinflammatory disease groups, moreover, M2-MDMs of CANDLE and Majeed pts constitutively released IL-8. As expected, IL-1ra was absent in unstimulated and stimulated DIRA M1-, and M2-MDSs. Moreover, CANLDE MDMs did not show an upregulation of IL-1ra distinct from IL-1 mediated diseases.

Conclusion: Taken together, differentiation of monocytes into M1 and M2 MDMs leads to variable but disease-specific regulation of pro-inflammatory cytokine and chemokine production. The value of this system in assessing monocyte and macrophage polarization defects and in assessing the proinflammatory dysregulation in various SAIDs need to be further explored.  Particularly, whether such systems proof useful in conditions where more than one cytokine/chemokine are dysregulated and in suggesting treatment targets needs to be evaluated in the future.

This work was supported by the DIR, NIAID, NIH.


Disclosure: F. Bhuyan, None; A. Almeida de Jesus, None; K. Johnson, None; J. Mitchell, None; Y. Huang, None; R. Goldbach-Mansky, None.

To cite this abstract in AMA style:

Bhuyan F, Almeida de Jesus A, Johnson K, Mitchell J, Huang Y, Goldbach-Mansky R. Characterization of Cytokine/chemokine Profile in Patient-derived M1/ M2 Macrophages to Identify Biomarkers for Genetically-defined Systemic Autoinflammatory Diseases [abstract]. Arthritis Rheumatol. 2020; 72 (suppl 10). https://acrabstracts.org/abstract/characterization-of-cytokine-chemokine-profile-in-patient-derived-m1-m2-macrophages-to-identify-biomarkers-for-genetically-defined-systemic-autoinflammatory-diseases/. Accessed .
  • Tweet
  • Click to email a link to a friend (Opens in new window) Email
  • Click to print (Opens in new window) Print

« Back to ACR Convergence 2020

ACR Meeting Abstracts - https://acrabstracts.org/abstract/characterization-of-cytokine-chemokine-profile-in-patient-derived-m1-m2-macrophages-to-identify-biomarkers-for-genetically-defined-systemic-autoinflammatory-diseases/

Advanced Search

Your Favorites

You can save and print a list of your favorite abstracts during your browser session by clicking the “Favorite” button at the bottom of any abstract. View your favorites »

All abstracts accepted to ACR Convergence are under media embargo once the ACR has notified presenters of their abstract’s acceptance. They may be presented at other meetings or published as manuscripts after this time but should not be discussed in non-scholarly venues or outlets. The following embargo policies are strictly enforced by the ACR.

Accepted abstracts are made available to the public online in advance of the meeting and are published in a special online supplement of our scientific journal, Arthritis & Rheumatology. Information contained in those abstracts may not be released until the abstracts appear online. In an exception to the media embargo, academic institutions, private organizations, and companies with products whose value may be influenced by information contained in an abstract may issue a press release to coincide with the availability of an ACR abstract on the ACR website. However, the ACR continues to require that information that goes beyond that contained in the abstract (e.g., discussion of the abstract done as part of editorial news coverage) is under media embargo until 10:00 AM ET on November 14, 2024. Journalists with access to embargoed information cannot release articles or editorial news coverage before this time. Editorial news coverage is considered original articles/videos developed by employed journalists to report facts, commentary, and subject matter expert quotes in a narrative form using a variety of sources (e.g., research, announcements, press releases, events, etc.).

Violation of this policy may result in the abstract being withdrawn from the meeting and other measures deemed appropriate. Authors are responsible for notifying colleagues, institutions, communications firms, and all other stakeholders related to the development or promotion of the abstract about this policy. If you have questions about the ACR abstract embargo policy, please contact ACR abstracts staff at [email protected].

Wiley

  • Online Journal
  • Privacy Policy
  • Permissions Policies
  • Cookie Preferences

© Copyright 2025 American College of Rheumatology